Analystreport

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Arena Pharmaceuticals, Inc.  (ARNA) 
Last arena pharmaceuticals, inc. earnings: 2/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: invest.arenapharm.com/investor-relations